Xenbucin
Title: Xenbucin
CAS Registry Number: 959-10-4
CAS Name: a-Ethyl-[1,1¢-biphenyl]-4-acetic acid
Additional Names: 2-(4-biphenylyl)butyric acid; a-(4-biphenylyl)butyric acid; a-(4-diphenylyl)butyric acid; a-(p-xenyl)butyric acid; 4-diphenylylethylacetic acid; 4-biphenylylethylacetic acid; ethyl-p-xenylacetic acid; a-ethyl-p-phenyl-a-toluic acid
Manufacturers' Codes: MG-1559
Trademarks: Liosol (Maggioni)
Molecular Formula: C16H16O2
Molecular Weight: 240.30
Percent Composition: C 79.97%, H 6.71%, O 13.32%
Literature References: Prepn: Blicke, Grier, J. Am. Chem. Soc. 65, 1725 (1943); Cavallini, Massarani, Farmaco Ed. Sci. 11, 167 (1956). Fibrinolytic activity: R. J. Gryglewski, M. Eckstein, Nature 214, 626 (1967).
Properties: Crystals from glacial acetic acid, mp 123-125°. Soluble in ethanol, methanol, acetone, carbon tetrachloride, benzene, ether, dimethylformamide. Practically insol in water.
Melting point: mp 123-125°
 
Derivative Type: trans-4-Phenylcyclohexylamine salt (1:1)
CAS Registry Number: 19992-80-4
Additional Names: Butixirate
Manufacturers' Codes: MG-5771
Trademarks: Flectar (Maggioni)
Molecular Formula: C28H33NO2
Molecular Weight: 415.57
Percent Composition: C 80.92%, H 8.00%, N 3.37%, O 7.70%
Literature References: Prepn, analgesic and anti-inflammatory properties: G. Cantarelli et al., Farmaco Ed. Sci. 24, 140 (1969); GB 1168542 (1969 to Maggioni), C.A. 72, 43197 (1970). Therapeutic effectiveness: P. Croce, Clin. Ter. 50, 241 (1969).
Properties: Crystals, mp 224-227°. LD50 i.p. in mice: 183 mM/kg (Cantarelli).
Melting point: mp 224-227°
Toxicity data: LD50 i.p. in mice: 183 mM/kg (Cantarelli)
 
Therap-Cat: Free acid as antilipemic; trans-4-phenylcyclohexylamine salt as analgesic, anti-inflammatory.
Keywords: Antilipemic.

Others monographs:
EcamsulePiperonylic AcidEthyl NitriteRetamine
TetrachloroethaneGeraniumBoron TribromidePhenglutarimide
AmmoniaBalofloxacinIridium HexafluorideMebendazole
AcetoinCalcium PermanganateNeodymiumToltrazuril
©2016 DrugLead US FDA&EMEA